Back
Rocket Pharmaceuticals, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
37
RCKT
Rocket Pharmaceuticals, Inc.
Last Price:
$3.73
Seasonality Move:
-13.93%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
Rocket Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.63 | Buy |
| 20-day SMA: | 3.5 | Buy |
| 50-day SMA: | 3.37 | Buy |
| 200-day SMA: | 3.96 | Sell |
| 8-day EMA: | 3.59 | Buy |
| 20-day EMA: | 2.79 | Buy |
| 50-day EMA: | 1.6 | Buy |
| 200-day EMA: | 0.49 | Buy |
Rocket Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | -1266237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.32 - 3.64) | Buy |
| Bollinger Bands (100): | (3.09 - 3.69) | Buy |
Rocket Pharmaceuticals, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals, Inc. Stock
Is Rocket Pharmaceuticals, Inc. Stock a Buy?
-
Rocket Pharmaceuticals, Inc. share price is 3.73 while RCKT 8-day simple moving average is 3.63, which is a Buy signal.
-
The stock price of RCKT is 3.73 while Rocket Pharmaceuticals, Inc. 20-day SMA is 3.50, which makes it a Buy.
-
Rocket Pharmaceuticals, Inc. 50-day simple moving average is 3.37 while RCKT share price is 3.73, making it a Buy technically.
-
RCKT stock price is 3.73 and Rocket Pharmaceuticals, Inc. 200-day simple moving average is 3.96, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
37
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Is Rocket Pharmaceuticals, Inc. a Buy or a Sell?
-
Rocket Pharmaceuticals, Inc. stock is rated a SellThe current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.73. The Score for RCKT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals, Inc. Stock Info
Market Cap:
403.7M
Price in USD:
3.73
Share Volume:
1.5M
Rocket Pharmaceuticals, Inc. 52-Week Range
52-Week High:
11.68
52-Week Low:
2.19
Sell
37
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Rocket Pharmaceuticals, Inc. Share Price Forecast
-
What is the Rocket Pharmaceuticals, Inc. stock price today?The Rocket Pharmaceuticals, Inc. stock price is 3.73 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals, Inc. is overvalued.
Is Rocket Pharmaceuticals, Inc. Stock a Buy?
-
Rocket Pharmaceuticals, Inc. share price is 3.73 while RCKT 8-day exponential moving average is 3.59, which is a Buy signal.
-
The stock price of RCKT is 3.73 while Rocket Pharmaceuticals, Inc. 20-day EMA is 2.79, which makes it a Buy.
-
Rocket Pharmaceuticals, Inc. 50-day exponential moving average is 1.60 while RCKT share price is 3.73, making it a Buy technically.
-
RCKT stock price is 3.73 and Rocket Pharmaceuticals, Inc. 200-day simple moving average is 0.49, creating a Buy signal.
Fundamental Analysis of Rocket Pharmaceuticals, Inc.
Is Rocket Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Rocket Pharmaceuticals, Inc.
Should I short Rocket Pharmaceuticals, Inc. stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is 0.89, suggesting Rocket Pharmaceuticals, Inc. is a Buy
-
Rocket Pharmaceuticals, Inc. Relative Strength Index (RSI) is 58.79, which suggest Rocket Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Rocket Pharmaceuticals, Inc. is (3.32 - 3.64), which suggest Rocket Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Rocket Pharmaceuticals, Inc. is (3.09 - 3.69), which suggest Rocket Pharmaceuticals, Inc. is a Buy
* Rocket Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.